U.K. Proposes Prescription-Only Status For Pseudoephedrine Products
This article was originally published in The Tan Sheet
Executive Summary
The U.K. Medicines and Healthcare products Regulatory Agency is proposing prescription status for pseudoephedrine- and ephedrine-containing drugs in order to prevent the illegal manufacture of methamphetamine
You may also be interested in...
Prescription Status For Pseudoephedrine In U.K. Put On Hold For Two Years
The British health authority will move pseudoephedrine- and ephedrine-containing OTCs to prescription-only status in two years unless the risk of the products' use in the illicit manufacturing of methamphetamine decreases by that time
Prescription Status For Pseudoephedrine In U.K. Put On Hold For Two Years
The British health authority will move pseudoephedrine- and ephedrine-containing OTCs to prescription-only status in two years unless the risk of the products' use in the illicit manufacturing of methamphetamine decreases by that time
Prescription Status For Pseudoephedrine In U.K. Put On Hold For Two Years
The British health authority will move pseudoephedrine- and ephedrine-containing OTCs to prescription-only status in two years unless the risk of the products' use in the illicit manufacturing of methamphetamine decreases by that time